Human malignant thyroid tumors displayed reduced levels of transforming growth factor β receptor type II messenger RNA and protein

Cancer Research

Volumn 57, Issue 10, 1997, Pages 2071-2076

  Lazzereschi, Davide ^a   Ranieri, Annalisa ^b   Mincione, Gabriella ^b   Taccogna, Silvia ^a   Nardi, Francesco ^a   Colletta, Giulia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; BLOTTING, NORTHERN; CARCINOMA, PAPILLARY; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; THYROID NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030954029     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Filmus, J., and Kerbel, R. S. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression. Curr. Opin. Oncol., 5: 123-129, 1993.
2. Miyazono, K., Ten Dijke, P., Ichijo, H., and Heldin. C. H. Receptors for TGFβ. Adv. Immunol., 55: 184-220, 1994.
3. Massagué, J., Attisano, L., and Wrana, J. L. The TGF-β family and its composite receptors. Trends Cell Biol., 4: 172-178, 1994.
4. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGFβ receptor. Nature (Lond.), 370: 341-346, 1994.
5. Massagué, J. TGFβ signaling: receptors, transducers and Mad proteins. Cell, 85: 947-950, 1996.
6. Park, K., Kim, S., Bang, Y., Park, J., Kim, N. K., Roberts, A. B., and Sporn M. B. Genetic changes in the transforming growth factor beta type II receptor gene in human gastric cancer cell: correlation with sensitivity to growth inhibition by TGFβ. Proc. Natl. Acad. Sci USA, 61: 8772-8776, 1994.
7. Kadin, M. E., Cavaille-Coll, M. W., Gertz, R., Massagué, J., Cheifetz, S., and George, D. Loss of receptors for TGF-β in human T-cell malignancies. Proc. Natl. Acad. Sci. USA, 91: 6002-6006, 1994.
8. Markowitz, S., Wang, J., Myeroff, L., Parson, R., Sun, L. Z., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. and Willson, J. K. V. Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
9. Tsuchima, T., Arai, M., Saji, M., Ohba, Y., Murakami, H., Ohmura, E., Sato, K., and Shizume, K. Effects of transforming growth factor beta on DNA synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology, 123: 1187-1194, 1988.
10. Colletta, G., Cirafici, A. M., and Di Carlo, A. Dual effect of TGF-β on rat thyroid cells: inhibition of thyrotropin induced proliferation and reduction of thyroid-specific differentiation markers. Cancer Res., 49: 3457-3462, 1989.
11. Grubeck-Loebenstein, B., Buchan, G., Sadeghi, R., Kissonerghis, M., Londei, M., Turner, M., Pirich, K., Niederle, B., Kassal, H., Walhausl, W., and Feldman, M. TGF-β regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J. Clin. Invest., 83: 764-770, 1989.
12. Hedigar, C., Williams E. D., and Sobin, L. H. Histological Typing of Thyroid Tumors. Berlin: Springer-Verlag, 1988.
13. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
14. Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
15. 1 phase of the cell cycle. Cell, 65: 701-713, 1991.
16. Kim, Y. I., Ahn, H. J., Zelner, D. J., Shaw, J. W., Lang, S., Kato, M., Oefelein, M. G., Miyazono, K., Nemeth, J. A., Kozlowski, J. M., and Lee, C. Loss of expression of transforming growth factor β type I and II receptors correlates with tumor grade in human prostate cancer. Clin. Cancer Res., 2: 1255-1261, 1996.
17. Markowitz, S. D., and Roberts, A. B. Tumor suppressor activity of the TGFβ pathway in human cancers. Cytokine Growth Factor Rev., 7: 93-102, 1996.
18. Brattain, M. G., Markowitz, S. D., and Willson, J. K. V. The type II transforming growth factor β receptor as a tumor suppressor gene. Curr. Opin. Onco., 8: 49-53, 1996.
19. Sun, L., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F., and Brattain M. G. Expression of TGF-β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269: 26449-26455, 1994.
20. Wang, J., Sun, L. Z., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., and Brattain, M. G. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270: 22044-22049, 1995.
21. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
22. Maestro, R., Gasparotto, D., Vukosavljevic, T., Barzan, L., Sulfaro, S., and Boiocchi, M. Three discrete regions of deletion at 3p in head and neck cancer. Cancer Res., 53: 5775-5779, 1993.
23. Hermann, M. A., Hay, I. D., Bartelt, D. H., Ritland, S. R., Dahl, R., Grant, C. S., and Jenkins, R. B. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J. Clin. Invest., 88: 1596-1604, 1996.
24. Suarez, H. G., du Villard, J. A., Severini, M., Caillou, B., Schlumberger, M., Tubiana, M., Parmentier, C., and Monier, R. Presence of mutations in all three Ras genes in human thyroid tumors. Oncogene, 5: 565-570, 1990.
25. Namba, H., Stanley, A. R., and Fagin, J. A. Point mutations of Ras oncogenes are an early event in thyroid tumorigenesis, Mol. Endocrinol., 4: 1474-1479, 1990.
26. Fusco, A., Grieco, M., Santoro, M., Berlingieri, M. T., Pilotti, S., Pierotti, M. A., Della Porta, G., and Vecchio, G. A new oncogene in human thyroid papillary carcinomas and their lymphonodal metastases. Nature (Lond.), 328: 159-164, 1989.
27. Bongarzone, I., Pierotti, M. A., Monzini, N., Mondellini, P., Manenti, G., Donghi, R., Pilotti, S. Grieco, M., Santoro, M., Fusco, A., Vecchio, G., and Della Porta, G. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 4: 1457-1462, 1989.
28. Di Renzo, M. F., Oliviero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., Pierotti, M. A., and Comoglio, P. M. Overexpression of the c-Met/HGF receptor gene in human thyroid carcinomas. Oncogene, 7: 2549-2553, 1992.
29. Viglietto, G., Maglione, D., Rambaldi, M., Cerutti, J., Romano, A., Trapasso, F., Fedele, M., Ippolito, P., Chiappetta, G., Botti, G. Fusco, A., and Persico, G. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PLGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene, 11: 1569-1579, 1995.
30. Blaydes, J. P., Schlumberger, M., Winford-Thomas, D., and Wyllie, F. S. Interaction between p53 and TGFβ1 in control of epithelial proliferation. Oncogene, 10: 307-317, 1995.
31. Blaydes, J. P., and Winford-Thomas, D. Loss of responsiveness to transforming growth factor β is tightly linked to tumorigenicity in a model of thyroid tumor progression. Int. J. Cancer, 65: 525-530, 1996.
32. Coppa, A., Mincione, G., Mammarella, S., Ranieri, A., and Colletta, G. Rat thyroid cells escaping from TGF-β negative growth control are still inhibited by this factor in the ability to trap iodide. Cell Growth & Differ., 6: 281-290, 1995.